The latest closing stock price for Gain Therapeutics as of March 07, 2025 is 1.88.
An investor who bought $1,000 worth of Gain Therapeutics stock at the IPO in 2021 would have $-832 today, roughly -1 times their original investment - a -35.99% compound annual growth rate over 4 years.
The all-time high Gain Therapeutics stock closing price was 15.80 on April 05, 2021.
The Gain Therapeutics 52-week high stock price is 4.74, which is 152.1% above the current share price.
The Gain Therapeutics 52-week low stock price is 0.89, which is 52.7% below the current share price.
The average Gain Therapeutics stock price for the last 52 weeks is 2.12.
An investor who bought $1,000 worth of Gain Therapeutics stock at the IPO in 2021 would have $-832 today, roughly -1 times their original investment - a -35.99% compound annual growth rate over 4 years.
The all-time high Gain Therapeutics stock closing price was 15.80 on April 05, 2021.
The Gain Therapeutics 52-week high stock price is 4.74, which is 152.1% above the current share price.
The Gain Therapeutics 52-week low stock price is 0.89, which is 52.7% below the current share price.
The average Gain Therapeutics stock price for the last 52 weeks is 2.12.